Abstract | PURPOSE: METHODS: Fifty-one consecutive patients who had inflamed pterygium (n = 32) or pinguecula (n = 19) were studied in a randomized, double-masked, controlled way. Objective signs (conjunctival congestion, redness, edema, and staining of cornea) and subjective complaints ( photophobia, pain, foreign-body sensation, discomfort, and tearing) were evaluated and scored. In addition, we evaluated total signs, total symptoms, and total score. Group 1 (n = 25) received topical indomethacin 0.1% solution and group 2 (n = 26) received a placebo six times daily for 3 days, then four times daily for 11 days. Patients were examined before and at days 3, 7, and 14 after the treatment began. RESULTS: In group 1 at day 3, the scores of total signs, total symptoms, and total score decreased (p = 0.001), and they further decreased after 14 days (p = 0.02 to p = 0.05). In group 2 at day 3 these parameters also significantly decreased (p = 0.01 to p = 0.02), but no further improvement occurred after 14 days. Comparing groups 1 and 2 revealed a decrease in scores in group 1 for total signs, total symptoms, and total score at days 3, 7, and 14 (p = 0.03 to p = 0.002) except for total signs after 14 days (p = NS). All the patients reported mild stinging for < 1 min after administration of the drops. CONCLUSIONS:
|
Authors | J Frucht-Pery, A Solomon, C S Siganos, T Shvartzenberg, C Richard, C Trinquand |
Journal | Cornea
(Cornea)
Vol. 16
Issue 1
Pg. 42-7
(Jan 1997)
ISSN: 0277-3740 [Print] United States |
PMID | 8985633
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Ophthalmic Solutions
- Indomethacin
|
Topics |
- Administration, Topical
- Adult
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, therapeutic use)
- Cell Division
- Conjunctivitis
(drug therapy, etiology)
- Double-Blind Method
- Female
- Follow-Up Studies
- Humans
- Indomethacin
(administration & dosage, therapeutic use)
- Male
- Middle Aged
- Ophthalmic Solutions
- Pterygium
(drug therapy, etiology)
- Retrospective Studies
- Treatment Outcome
|